157 related articles for article (PubMed ID: 37921156)
1. Evaluation of Cytotoxicity and Antimicrobial Activity of Experimental Composites Containing Chitosan-Silver Oxide Particles Against Two Main Pathogenic Bacteria in Periodontal Disease.
Nasrabadi N; Ramezanian N; Ghorbanian P; Forouzanfar A; Mohammadipour HS
Protein Pept Lett; 2024; 31(2):97-106. PubMed ID: 37921156
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial and antibiofilm activities of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) against periodontopathic bacteria.
Sun M; Zhou Z; Dong J; Zhang J; Xia Y; Shu R
Microb Pathog; 2016 Oct; 99():196-203. PubMed ID: 27565090
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial effect of silver (I) carbohydrate complexes on oral pathogenic key species in vitro.
Reise M; Gottschaldt M; Matz C; Völpel A; Jandt KD; Schubert US; Sigusch BW
BMC Oral Health; 2016 Mar; 16():42. PubMed ID: 27009305
[TBL] [Abstract][Full Text] [Related]
4. Biological evaluation of silver nanoparticles incorporated into chitosan-based membranes.
Shao J; Yu N; Kolwijck E; Wang B; Tan KW; Jansen JA; Walboomers XF; Yang F
Nanomedicine (Lond); 2017 Nov; 12(22):2771-2785. PubMed ID: 28967828
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of red wine and oenological extracts against periodontal pathogens in a validated oral biofilm model.
Sánchez MC; Ribeiro-Vidal H; Esteban-Fernández A; Bartolomé B; Figuero E; Moreno-Arribas MV; Sanz M; Herrera D
BMC Complement Altern Med; 2019 Jun; 19(1):145. PubMed ID: 31226983
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Antimicrobial Peptide Nal-P-113 on Inhibiting Periodontal Pathogens and Improving Periodontal Status.
Wang H; Ai L; Zhang Y; Cheng J; Yu H; Li C; Zhang D; Pan Y; Lin L
Biomed Res Int; 2018; 2018():1805793. PubMed ID: 29736391
[TBL] [Abstract][Full Text] [Related]
7. Copaifera reticulata oleoresin: Chemical characterization and antibacterial properties against oral pathogens.
Bardají DK; da Silva JJ; Bianchi TC; de Souza Eugênio D; de Oliveira PF; Leandro LF; Rogez HL; Venezianni RC; Ambrosio SR; Tavares DC; Bastos JK; Martins CH
Anaerobe; 2016 Aug; 40():18-27. PubMed ID: 27118478
[TBL] [Abstract][Full Text] [Related]
8. Selected dietary (poly)phenols inhibit periodontal pathogen growth and biofilm formation.
Shahzad M; Millhouse E; Culshaw S; Edwards CA; Ramage G; Combet E
Food Funct; 2015 Mar; 6(3):719-29. PubMed ID: 25585200
[TBL] [Abstract][Full Text] [Related]
9. Lactobacillus reuteri AN417 cell-free culture supernatant as a novel antibacterial agent targeting oral pathogenic bacteria.
Yang KM; Kim JS; Kim HS; Kim YY; Oh JK; Jung HW; Park DS; Bae KH
Sci Rep; 2021 Jan; 11(1):1631. PubMed ID: 33452304
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of antibiotics loaded cellulose nanofiber and κ-carrageenan oligosaccharide composite hydrogels for periodontitis treatment.
Johnson A; Kong F; Miao S; Lin HV; Thomas S; Huang YC; Kong ZL
Sci Rep; 2020 Oct; 10(1):18037. PubMed ID: 33093521
[TBL] [Abstract][Full Text] [Related]
11. Effects of chitosan particles in periodontal pathogens and gingival fibroblasts.
Arancibia R; Maturana C; Silva D; Tobar N; Tapia C; Salazar JC; Martínez J; Smith PC
J Dent Res; 2013 Aug; 92(8):740-5. PubMed ID: 23788611
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of NO-releasing compounds against periodontal pathogens.
Shim JS; Park DS; Baek DH; Jha N; Park SI; Yun HJ; Kim WJ; Ryu JJ
PLoS One; 2018; 13(10):e0199998. PubMed ID: 30286117
[TBL] [Abstract][Full Text] [Related]
13. Combined antioxidant effects of Neem extract, bacteria, red blood cells and Lysozyme: possible relation to periodontal disease.
Heyman L; Houri-Haddad Y; Heyman SN; Ginsburg I; Gleitman Y; Feuerstein O
BMC Complement Altern Med; 2017 Aug; 17(1):399. PubMed ID: 28797303
[TBL] [Abstract][Full Text] [Related]
14. Melatonin Receptor Agonists as the "Perioceutics" Agents for Periodontal Disease through Modulation of Porphyromonas gingivalis Virulence and Inflammatory Response.
Zhou W; Zhang X; Zhu CL; He ZY; Liang JP; Song ZC
PLoS One; 2016; 11(11):e0166442. PubMed ID: 27832188
[TBL] [Abstract][Full Text] [Related]
15. Capping Agent-Dependent Toxicity and Antimicrobial Activity of Silver Nanoparticles: An
Niska K; Knap N; Kędzia A; Jaskiewicz M; Kamysz W; Inkielewicz-Stepniak I
Int J Med Sci; 2016; 13(10):772-782. PubMed ID: 27766027
[No Abstract] [Full Text] [Related]
16. Antibacterial activity of povidone-iodine against an artificial biofilm of Porphyromonas gingivalis and Fusobacterium nucleatum.
Hosaka Y; Saito A; Maeda R; Fukaya C; Morikawa S; Makino A; Ishihara K; Nakagawa T
Arch Oral Biol; 2012 Apr; 57(4):364-8. PubMed ID: 21958970
[TBL] [Abstract][Full Text] [Related]
17. NOX1/2 activation in human gingival fibroblasts by Fusobacterium nucleatum facilitates attachment of Porphyromonas gingivalis.
Ahn SH; Song JE; Kim S; Cho SH; Lim YK; Kook JK; Kook MS; Lee TH
Arch Microbiol; 2016 Aug; 198(6):573-83. PubMed ID: 27071620
[TBL] [Abstract][Full Text] [Related]
18. Rice peptide with amino acid substitution inhibits biofilm formation by Porphyromonas gingivalis and Fusobacterium nucleatum.
Matsugishi A; Aoki-Nonaka Y; Yokoji-Takeuchi M; Yamada-Hara M; Mikami Y; Hayatsu M; Terao Y; Domon H; Taniguchi M; Takahashi N; Yamazaki K; Tabeta K
Arch Oral Biol; 2021 Jan; 121():104956. PubMed ID: 33157493
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional Ag
Zagloul H; Dhahri M; Bashal AH; Khaleil MM; Habeeb TH; Khalil KD
Int J Biol Macromol; 2024 Apr; 264(Pt 1):129990. PubMed ID: 38360246
[TBL] [Abstract][Full Text] [Related]
20. Strong cytotoxicity to human gingival fibroblasts by Porphyromonas gingivalis ATCC 33277.
Johansson A; Bergenholtz A; Holm SE
J Periodontal Res; 1996 Oct; 31(7):477-82. PubMed ID: 8915950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
